GLP-1 (RT)| 10mg Research Vial

Retatrutide | 10mg Research Vial

Oceanic Research Australia supplies the highest quality research-grade peptide compounds, rigorously tested for purity and consistency.

Product Details

• Compound: Retatrutide (GLP-1/GIP/Glucagon Triple Receptor Agonist)
• Amount: 10mg per vial
• Form: Lyophilised peptide
• Purity: ≥99% (verified by third-party HPLC analysis)
• Certificate of Analysis: Available upon request

About Retatrutide

Retatrutide is a synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. It is an area of significant scientific interest and is widely studied in laboratory and in-vitro research settings. All research is conducted under controlled laboratory conditions.

⚠️ Important Disclaimer

For Research Purposes Only. This product is strictly intended for in-vitro laboratory research and scientific study. It is NOT intended for human or animal consumption, therapeutic use, or any other purpose outside of controlled research environments.

• Not for human consumption
• Not for veterinary use
• Must be handled by qualified researchers in a laboratory setting
• You must be 18 years or older to purchase
• Keep out of reach of children
• Store at -20°C in a dry, dark environment

Quality Assurance

Every batch supplied by Oceanic Research Australia undergoes rigorous third-party testing. We provide full certificates of analysis (CoA) to ensure transparency and confidence in every compound we supply.